|
AZN
|
Astrazeneca PLC
|
3.05%
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
2.27%
|
US
|
NASDAQ
|
|
MRK
|
Merck & Company, Inc.
|
2.11%
|
US
|
NYSE
|
|
GILD
|
Gilead Sciences, Inc.
|
2.08%
|
US
|
NASDAQ
|
|
PFE
|
Pfizer, Inc.
|
2.07%
|
US
|
NYSE
|
|
TMO
|
Thermo Fisher Scientific Inc
|
2.04%
|
US
|
NYSE
|
|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
2.00%
|
US
|
NASDAQ
|
|
LLY
|
Eli Lilly and Company
|
2.00%
|
US
|
NYSE
|
|
ADM
|
Archer-Daniels-Midland Company
|
1.99%
|
US
|
NYSE
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
1.94%
|
US
|
NASDAQ
|
|
CTVA
|
Corteva, Inc.
|
1.93%
|
US
|
NYSE
|
|
A
|
Agilent Technologies, Inc.
|
1.91%
|
US
|
NYSE
|
|
DHR
|
Danaher Corporation
|
1.84%
|
US
|
NYSE
|
|
REGN
|
Regeneron Pharmaceuticals, Inc.
|
1.83%
|
US
|
NASDAQ
|
|
BIIB
|
Biogen Idec Inc.
|
1.75%
|
US
|
NASDAQ
|
|
JNJ
|
Johnson & Johnson
|
1.73%
|
US
|
NYSE
|
|
FMC
|
FMC Corporation
|
1.73%
|
US
|
NYSE
|
|
AMGN
|
Amgen Inc.
|
1.70%
|
US
|
NASDAQ
|
|
PKI
|
PerkinElmer, Inc.
|
1.69%
|
US
|
NYSE
|
|
BMRN
|
BioMarin Pharmaceutical Inc.
|
1.67%
|
US
|
NASDAQ
|